Tandem Diabetes Care | TNDM - Marktkapitalisierung

Aktienkurs
20.36
Täglich Wechseln
-0.32 -1.55%
Monatlich
-16.08%
Jährlich
12.74%
Q2 Prognose
19.92




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Align Technology USD 11.2B 2.13B 2025-12
AtriCure USD 1.97B 215M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 95.61B 2.35B 2026-04
Cooper Companies USD 15.95B 2.05B 2025-12
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 47.05B 884M 2026-04
Eli Lilly USD 1.02T 293.84B 2025-12
Globus Medical USD 11.69B 3.95B 2025-12
ICU Medical USD 3.52B 561M 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
J&J USD 561.65B 17.5B 2026-04
Masimo USD 6.84B 839M 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Orthofix International USD 604M 25M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12